MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-24-0021832
Elango Genetics Private Limited - life sciences in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹46.45 Lakh
▲ 15% YoY
Net profit · FY 2025
₹3.84 Lakh
Net margin 8.3%
EBITDA · FY 2025
₹7.64 Lakh
EBITDA margin 16.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹48 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Elango Genetics Private Limited
Data last updated:
Elango Genetics Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 07 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2019PTC129144. Its GSTIN is 33AAFCE4779A1ZU (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Varalakshmi Theyagarajan and Thiyagarajan Natesa Mudaliar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sfn0. 38/16. Kotisvarannagar Krishnapuram Village Ponneri Tk, Chennai, Tamil Nadu, India – 601204.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.45 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹3.84 Lakh (net margin 8.3%) and EBITDA of ₹7.64 Lakh (EBITDA margin 16.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 152% over five years.
The company is associated with 1 brand: Elango Genetics. As per MCA filings, the company has open charges of ₹48 Lakh on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹9 Lakh; the latest was in December 2021. Its 10 peer companies in the Biotechnology industry (Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Visakha Enviro Labs and Consultants Private Limited with revenue of ₹47.04 Lakh.
Elango Genetics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0021832). For more details, the company can be reached via its website elangogenetics.com.
Company Details of Elango Genetics Private Limited
CIN U74999TN2019PTC129144
Registration Number 129144
Incorporation Date 07 May 2019
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TN-24-0021832
Recognitions & Rankings of Elango Genetics
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressSfn0. 38/16. Kotisvarannagar Krishnapuram Village Ponneri Tk, Chennai, Tamil Nadu, India – 601204
- IndustryLife Sciences, Biotechnology
Comprehensive company report
Elango Genetics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Elango Genetics Private Limited
Elango Genetics operates one associated brand: Elango Genetics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides genomic-based contract research services for clients. | elangogenetics.com |
Business Activity of Elango Genetics Private Limited
The main business activity of Elango Genetics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elango Genetics Private Limited FY 2025 filings available
Elango Genetics Private Limited reported revenue of ₹46.45 Lakh (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹46.45 Lakh ▲ 15%
Net profit · FY 2025
₹3.84 Lakh margin 8.3%
EBITDA · FY 2025
₹7.64 Lakh margin 16.4%
Compounded Annual Growth Rate (CAGR) of Elango Genetics Private Limited
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 8%
5 years · compounded
▲ 152%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▲ 9%
5 years · compounded
▲ 54%
Revenue has grown at a compounded annual rate (CAGR) of 152% over five years, including 15% growth in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elango Genetics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.64 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.84 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elango Genetics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elango Genetics are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Elango Genetics Private Limited
Elango Genetics has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varalakshmi Theyagarajan | Director | 07 May 2019 | 7 Years 5 Months | Current |
| Thiyagarajan Natesa Mudaliar | Director | 07 May 2019 | 7 Years 5 Months | Current |
Peer Comparison of Elango Genetics Private Limited
Elango Genetics Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Visakha Enviro Labs and Consultants Private Limited | ₹47.04 Lakh (FY 2025) | •••• | •••• | 59.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Reseda Lifesciences Private Limited | ₹47.04 Lakh (FY 2025) | •••• | •••• | -86.0% | •••• | Bangalore, Karnataka, India |
| Occamy Bioscience Private Limited | ₹47.03 Lakh (FY 2025) | •••• | •••• | 66.0% | •••• | Panvel, Maharashtra, India |
| Prismglass Research Limited | ₹46.63 Lakh (FY 2022) | •••• | •••• | 3419.0% | •••• | Dhaula, Punjab, India |
| Mediomix Diagnosis and Bioresearch Private Limited | ₹46.6 Lakh (FY 2024) | •••• | •••• | 4136.0% | •••• | Bangalore, Karnataka, India |
| Elango Genetics Private Limited this company | ₹46.45 Lakh (FY 2025) | •••• | •••• | 15.0% | •••• | Chennai, Tamil Nadu, India |
| Goodwin Biotechnology India Private Limited | ₹45.55 Lakh (FY 2019) | •••• | •••• | 5279.0% | •••• | Panjim, Goa, India |
| Prajna Bio Sciences Private Limited | ₹45.42 Lakh (FY 2025) | •••• | •••• | 107.0% | •••• | Hubli, Karnataka, India |
| Kredd Scientific Nascence Private Limited | ₹44.95 Lakh (FY 2025) | •••• | •••• | •••• | Aurangabad, Maharashtra, India | |
| Bio Bharati Life Science Private Limited | ₹44.86 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Kolkata, West Bengal, India |
| Anantaurja Bharat Private Limited | ₹44.83 Lakh (FY 2019) | •••• | •••• | 205.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Elango Genetics by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Elango Genetics Private Limited
Elango Genetics Private Limited is audited by NASEEMUNNISA & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NASEEMUNNISA & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Elango Genetics Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elango Genetics Private Limited
Open charges
₹48 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2019 | Others | ₹48 Lakh | Open |
Total charge records: 1 View all charges
Deals & Funding of Elango Genetics Private Limited
Elango Genetics Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹9 Lakh; the latest was in December 2021.
Total deals
1
Funding round
1
Disclosed funding
₹9 Lakh
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2021 | Funding round | ₹9 Lakh | Investors: 2 individuals |
Premium access
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Elango Genetics Private Limited
Employment history and EPFO contributions of people linked to Elango Genetics.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Elango Genetics Private Limited
Elango Genetics Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Thiyagarajan Natesa Mudaliar was appointed as Director on 07 May 2019.
AGM
Elango Genetics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elango Genetics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others of Rs. 48.00 Lakh registered on 05 Dec 2019 with Charge ID 100316869 was modified on 09 May 2022.
Charges
A charge with Others amounted to Rs. 48.00 Lakh with Charge ID 100316869 was registered on 05 Dec 2019.
Appointed
Thiyagarajan Natesa Mudaliar was appointed as Director.
Appointed
Varalakshmi Theyagarajan was appointed as Director.
Incorporation
07 May 2019
Elango Genetics Private Limited was registered on 07 May 2019 with Roc Chennai & aged 7 years 5 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Elango Genetics Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elango Genetics Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elango Genetics Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elango Genetics Private Limited
Elango Genetics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCE4779A1ZU | Tamil Nadu | Active | 26 Sep 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elango Genetics Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elango Genetics Private Limited
Elango Genetics is an active private limited company based in Chennai, Tamil Nadu, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 07 May 2019 (7+ years old) and is registered under CIN U74999TN2019PTC129144.
Elango Genetics reported revenue of ₹46.45 Lakh for FY 2025 (up 15% YoY).
Elango Genetics has 2 current directors:
- Varalakshmi Theyagarajan - Director
- Thiyagarajan Natesa Mudaliar - Director
Elango Genetics reported a net profit of ₹3.84 Lakh (net margin 8.3%) and EBITDA of ₹7.64 Lakh (EBITDA margin 16.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Elango Genetics is 8% over three years and 152% over five years. In the latest year (FY 2025) revenue rose 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Elango Genetics is 33AAFCE4779A1ZU, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Elango Genetics is U74999TN2019PTC129144. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elango Genetics was incorporated on 07 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
Elango Genetics has 1 deal on record (1 funding round), with disclosed funding of ₹9 Lakh; the latest was in December 2021.
The peers of Elango Genetics by revenue are Visakha Enviro Labs and Consultants Private Limited, Reseda Lifesciences Private Limited, Occamy Bioscience Private Limited, Prismglass Research Limited, Mediomix Diagnosis and Bioresearch Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Thiyagarajan Natesa Mudaliar was appointed as Director on 07 May 2019. Varalakshmi Theyagarajan was appointed as Director on 07 May 2019.